1. Home
  2. |Insights
  3. |Email Exchange Constitutes “Timely, Formal Challenge” for Purposes of Avoiding Blue & Gold Waiver Rule

Email Exchange Constitutes “Timely, Formal Challenge” for Purposes of Avoiding Blue & Gold Waiver Rule

Client Alert | 4 min read | 05.20.22

Last week, in SEKRI, Inc. v. U.S., No. 21-1936 (Fed. Cir. May 13, 2022), the U.S. Court of Appeals for the Federal Circuit appeared to chip away at the scope of the Blue & Gold waiver rule. The Court held that SEKRI, Inc. (“SEKRI”)—which neither submitted a proposal nor filed a protest prior to the relevant proposal submission deadline—had standing to challenge the terms of a solicitation, and was not untimely in doing so, because its representative had exchanged emails with the agency regarding the terms of the underlying solicitation. While the Federal Circuit cabined its holding to the specific facts at issue, the ruling raises questions about whether the Blue & Gold waiver rule is susceptible to further limitation under a similar rationale.

As background, the Javits-Wagner-O’Day (“JWOD”) Act requires the government to procure certain commodities from nonprofit agencies that employ persons who are blind or otherwise severely disabled. The AbilityOne Program implements the procurement system mandated by the JWOD Act. And the FAR, at Subpart 8.7, similarly mandates that federal agencies utilize designated AbilityOne suppliers for specific commodities. SEKRI involved a Defense Logistics Agency (“DLA”) procurement for one of those commodities: Advanced Tactical Assault Panels (“ATAP”). 

In April 2020, DLA sought, via a full-and-open, competitive bidding process, a single supplier for ATAP. SourceAmerica, a nonprofit agency supporting AbilityOne suppliers, notified DLA via a series of emails that SEKRI was a designated mandatory supplier of ATAP under the AbilityOne Program. In response, DLA explained that a full-and-open competition best met its needs, and DLA invited SEKRI to submit a proposal. Beyond that email correspondence, neither SourceAmerica nor SEKRI raised any objection or filed a pre-award protest prior to the proposal submission deadline.

More than three months after that deadline, SEKRI filed a protest at the Court of Federal Claims (“COFC”) challenging DLA’s solicitation as violating the JWOD Act and the FAR. The COFC dismissed the protest, holding that SEKRI lacked standing because it had not submitted a proposal, and that its protest was untimely. As to the latter finding, the COFC ruled that because SEKRI had not filed its complaint prior to the close of bidding, its “belated protest fits squarely within the Blue & Gold rule.”

The Federal Circuit reversed. In so doing, the Court held that SEKRI had standing even though it did not submit a proposal because it was a designated mandatory source of ATAP under the AbilityOne Program as implemented by the FAR. The Court ruled that “it would not make sense to impose upon mandatory sources an affirmative obligation to monitor the federal government’s solicitations to identify attempts to circumvent the AbilityOne Program.” 

In finding SEKRI’s protest timely notwithstanding the Blue & Gold waiver rule, the Court relied on its recent decision in Harmonia Holdings Grp., LLC v. U.S., 20 F.4th 759 (Fed Cir. 2021) (which we covered here). In Harmonia, the Court held a protester’s timely, formal challenge to the terms of the solicitation—in that case, a pre-award agency level protest—“removes a case from the ambit of Blue & Gold and its progeny.”  Here, the Court explained that because SEKRI was a mandatory source supplier under the JWOD Act and the FAR, and DLA was notified of that fact via email before the proposal submission deadline, that sufficed to “remove[] this case from the application of the Blue & Gold standard of waiver.” The Court opined that allowing DLA to proceed with the solicitation despite knowledge of the availability of a mandatory source would “turn[] the JWOD Act on its head.” 

While the Federal Circuit’s decision is limited to its facts, it nonetheless raises a number of questions regarding the future application of the Blue & Gold waiver rule. For example, does any email to a contracting agency questioning an agency’s procurement plan constitute a “timely, formal challenge” to the terms of a solicitation, thereby satisfying the Harmonia standard? And does an email flagging an apparent agency violation of any statutory or regulatory mandate—e.g., the Rule of Two, or lack of advanced planning to justify a sole source award—relieve a protester from its obligation to file a pre-award protest to preserve its rights? 

For the time being, SEKRI should be read only to apply to procurements implicating AbilityOne commodities, Blue & Gold remains intact, and bidders who identify an error on the face of a solicitation should file a pre-award protest to protect their rights. But SEKRI opens the door to the possibility that, where a procuring agency fails to comply with mandatory statutory or FAR requirements, a protester may have rights to bring a challenge, and should not assume waiver, even if it did not file a pre-award protest.  

Insights

Client Alert | 6 min read | 03.26.24

California Office of Health Care Affordability Notice Requirement for Material Change Transactions Closing on or After April 1, 2024

Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur....